[
    [
        {
            "time": "2018-07-10",
            "original_text": "智飞生物：与默沙东签署五价轮状疫苗补充协议",
            "features": {
                "keywords": [
                    "智飞生物",
                    "默沙东",
                    "五价轮状疫苗",
                    "补充协议"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物：与默沙东签署五价轮状疫苗补充协议",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-10",
            "original_text": "智飞生物大涨5.13%，报48.36元",
            "features": {
                "keywords": [
                    "智飞生物",
                    "大涨",
                    "5.13%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物大涨5.13%，报48.36元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2018-07-10",
            "original_text": "【医药-智飞生物(300122)】江琦：公司点评：五价轮状病毒疫苗确定基础采购额，稳定增长的现金流品种",
            "features": {
                "keywords": [
                    "智飞生物",
                    "五价轮状病毒疫苗",
                    "基础采购额",
                    "稳定增长",
                    "现金流"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药-智飞生物(300122)】江琦：公司点评：五价轮状病毒疫苗确定基础采购额，稳定增长的现金流品种",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]